[ad_1]
David Adlington
JPMorgan Chase & Co, Analysis Division
Good afternoon, all people. I am David Adlington. I head up the JPMorgan analysis crew for MedTech in London for JPMorgan. It is my pleasure to introduce Dr. Montag and Jochen, CFO as nicely from Healthineers. There shall be a presentation in a second. Thanks.
Bernhard Montag
President, CEO & Chairman of Administration Board
So thanks, David. In order a preview, I imply, that is going to be a vital 12 months for Siemens Healthineers right here as a result of a lot of you recognize that extra shares shall be out there quickly, sure.
So that’s the reason I’ll begin a bit bit to start with about actually who we’re in order that that is actually clear. And alternatively, for this reason we crew up right this moment, and Jochen will even current, which implies I want to talk very quick in order that he has additionally a while and does not criticize me too laborious afterwards.
So with that mentioned, who’re we? We’re a transparent market chief and compounder. We’re a transparent #1 in imaging and in precision remedy. We’re seen because the go-to associate for the massive establishments for the educational medical facilities, 90% of them work with us.
We’re world, world within the sense of being current in 70 international locations. We now have an put in base of about 700,000 techniques and a powerful quantity, 3 billion affected person contact factors per 12 months.
R&D is for us not a price, however the lifeblood of
[ad_2]
